Box score
Convergent Therapeutics, Inc.
Reported $22.2M sold in a new Form D filed August 13, 2024 (Cambridge, Massachusetts).
- Biggest raise
- $22.2M filed Aug 13, 2024
- League
- Bio & Health Biotechnology
- Based in
- Cambridge, Massachusetts
- Season rank
- #206 of 1,389 in the Bio & Health League; #907 of 12,443 overall (2024)
- Incorporated
- 2020
- Entity
- Corporation
Form D filings since 2024 1
| Filed | Form | Sold | Offering | Filing |
|---|---|---|---|---|
| 2024-08-13 | New notice | $22.2M | $40M | SEC |
Amounts are cumulative for each offering as of the filing date, so an amendment can repeat or update an earlier figure; filings are not added together. CIK 1978126.
Similar raises, 2024
| # | Company | League | Raised |
|---|---|---|---|
| 1 | Tasca Therapeutics Corp rookie | Bio & Health | $24.1M |
| 2 | Myrobalan Therapeutics Holding, Inc. rookie | Bio & Health | $24M |
| 3 | Qlaris Bio, Inc. | Bio & Health | $24M |
| 4 | Amplitude Vascular Systems, Inc. | Bio & Health | $23.6M |
| 5 | Eleanor Health Holdings, LLC | Bio & Health | $22.2M |
| 6 | Superluminal Medicines, Inc. | Bio & Health | $20M |